Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Marksans Pharma Limited
MARKSANS | NSE
163.08
INR-2.12
-1.28%
MARKSANS | NSE
Loading StockChartView...
About Marksans Pharma Limited
Sector
Healthcare
Industry
Drug Manufacturers-General
Earnings date
31/03/2024
As of date
27/03/2026
Close
163.08
Open
164.05
High
165.50
Low
160.50
Marksans Pharma Limited together with its subsidiaries engages in the research and development manufacturing marketing distribution and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics benign prostatic hyperplasia antidiabetic epilepsy anti-inflammatory hyperparathyroidism diabetes antacids neurology cardiovascular hormonal oncology gastroenterology antidiabetic pain management gynecology antibiotic antifungal antiulceratives vitamins dermatology cephalosporins injectables anti-allergy antibacterial and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai India.
View LessMARKSANS | NSE
Risk
40.5
Sharpe
-0.65
Luna's Score
48/100
Recommendation
Hold
Luna says (MARKSANS | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
53.9%1 month
40.5%3 months
37.1%6 months
34.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
38.34
Fwd. PE
-
Price to book
6.21
Debt to equity
0.12
Debt to assets
0.09
Ent. to EBITDA
24.31
Ent. to rev.
5.69
PEG
-
Other Fundamentals
EBITDA
4.89B
MarketCap
74.26B
MarketCap(USD)
784.70M
Div. yield
0.21
Op. margin
18.29
Erngs. growth
28.90
Rev. growth
18.10
Ret. on equity
16.35
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
15.69
Range1M
24.80
Range3M
35.74
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.58
Price X volume
176.64M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 24.31 | 25.64 | Par |
| Ent. to Revenue | 5.69 | 6.59 | Par |
| PE Ratio | 38.34 | 41.48 | Par |
| Price to Book | 6.21 | 10.46 | Cheaper |
| Dividend Yield | 0.21 | 0.96 | Poor |
| Std. Deviation (3M) | 37.09 | 41.14 | Par |
| Debt to Equity | 0.12 | 0.14 | Par |
| Debt to Assets | 0.09 | 0.08 | Par |
| Market Cap | 74.26B | 186.70B | Emerging |
